NCT04542252View on ClinicalTrials.gov

Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

December 22, 2020

Study Completion Date

January 29, 2021

Conditions
Drug Drug Interaction
Interventions
DRUG

SyB V-1901

SyB V-1901 10 mg via IV infusion for 2 hours

DRUG

Cyclosporine

200 mg Capsule

Trial Locations (1)

Unknown

Research Site, Hachioji-shi

Sponsors
All Listed Sponsors
lead

SymBio Pharmaceuticals

INDUSTRY